nimustine has been researched along with Disease Models, Animal in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (40.00) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Braisted, J; Dranchak, P; Earnest, TW; Gu, X; Hoon, MA; Inglese, J; Oliphant, E; Solinski, HJ | 1 |
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Dai, C; Dong, J; Huang, Q; Lan, Q; Li, M; Liu, B; Lu, Z; Ma, J; Ma, X; Xie, T | 1 |
| Bouwman, P; Jonkers, J; Klarenbeek, S; van de Ven, M; van der Burg, E; van der Gulden, H | 1 |
| Kikuchi, T; Kumabe, T; Sonoda, Y; Sugiyama, S; Tominaga, T; Yamashita, Y | 1 |
| Kikuchi, T; Kumabe, T; Saito, R; Sugiyama, S; Tominaga, T; Yamashita, Y | 1 |
| Kageyama, N; Kida, Y; Kobayashi, T; Shibuya, N; Yoshida, J | 1 |
| Hayakawa, T; Mogami, H; Nakata, Y; Sakamoto, Y; Shimizu, K; Ushio, Y; Yoshida, T | 1 |
| Hayakawa, T; Kato, A; Mogami, H; Nakata, Y; Ushio, Y; Yamada, K; Yoshida, T | 1 |
| Arai, Y; Kabuto, M; Kitai, R; Kobayashi, H; Kubota, T; Nakagawa, T | 1 |
| Mima, T; Mori, K; Mostafa, MG | 1 |
| Koulousakis, A; Shimizu, K; Sturm, V; Yoshida, TK | 1 |
| Bamberg, M; Budach, V; Gerhard, L; Stuschke, M | 1 |
| Katakura, R; Kitahara, M; Sasaki, T; Suzuki, J | 1 |
| Matsutani, M; Nagashima, T; Orii, H; Tamura, A | 1 |
15 other study(ies) available for nimustine and Disease Models, Animal
| Article | Year |
|---|---|
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, Spinal; Humans; Mice, Inbred C57BL; Mice, Knockout; Neurons; Pruritus; Receptors, Atrial Natriuretic Factor; Reproducibility of Results; Signal Transduction; Small Molecule Libraries | 2019 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Hyperbaric oxygen therapy sensitizes nimustine treatment for glioma in mice.
Topics: Animals; Antineoplastic Agents; Biomarkers; Body Weight; Cell Line, Tumor; Disease Models, Animal; Glioma; Humans; Hyperbaric Oxygenation; Hypoxia-Inducible Factor 1, alpha Subunit; Inflammation; Mice; Mice, Transgenic; Models, Biological; NF-kappa B; Nimustine; Signal Transduction; Tumor Burden; Tumor Necrosis Factor-alpha; Xenograft Model Antitumor Assays | 2016 |
Prophylactic window therapy with the clinical poly(ADP-ribose) polymerase inhibitor olaparib delays BRCA1-deficient mammary tumour formation in mice.
Topics: Animals; Antineoplastic Agents; BRCA1 Protein; Cisplatin; Disease Models, Animal; DNA Repair; Female; Germ-Line Mutation; Humans; Mammary Neoplasms, Animal; Mice; Nimustine; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Tumor Suppressor Proteins | 2017 |
Enhanced antitumor effect of combined-modality treatment using convection-enhanced delivery of hydrophilic nitrosourea with irradiation or systemic administration of temozolomide in intracranial brain tumor xenografts.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cell Line, Tumor; Combined Modality Therapy; Convection; Cranial Irradiation; Dacarbazine; Disease Models, Animal; Drug Delivery Systems; Gliosarcoma; Injections, Intraperitoneal; Male; Nimustine; Rats; Rats, Inbred F344; Survival Analysis; Survival Rate; Temozolomide; Treatment Outcome; Xenograft Model Antitumor Assays | 2008 |
Safety and efficacy of convection-enhanced delivery of ACNU, a hydrophilic nitrosourea, in intracranial brain tumor models.
Topics: Animals; Antineoplastic Agents; Brain; Brain Neoplasms; Cell Line, Tumor; Chemotherapy, Cancer, Regional Perfusion; Convection; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Delivery Systems; Gliosarcoma; Humans; Male; Maximum Tolerated Dose; Nimustine; Random Allocation; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Survival Analysis; Tissue Distribution; Treatment Outcome; Xenograft Model Antitumor Assays | 2007 |
[Chemotherapy of a rat brain tumor model by innoculation of ascites hepatoma cells--effects of ACNU and adriamycin, and their tissue concentrations (author's transl)].
Topics: Animals; Blood-Brain Barrier; Brain Neoplasms; Cells, Cultured; Disease Models, Animal; Doxorubicin; Liver Neoplasms, Experimental; Male; Nimustine; Nitrosourea Compounds; Rats | 1981 |
[Meningeal gliomatosis models as a chemosensitivity assay system].
Topics: Animals; Antineoplastic Agents; Carmustine; Cell Division; Cell Survival; Disease Models, Animal; Drug Resistance; Glioma; Male; Meningeal Neoplasms; Nimustine; Nitrosourea Compounds; Rats; Rats, Inbred F344; Rats, Inbred Strains | 1984 |
[Development of ACNU-resistant meningeal gliomatosis models: establishment of resistant rat glioma subline against ACNU].
Topics: Animals; Antineoplastic Agents; Cell Division; Cell Line; Cell Survival; Cells, Cultured; Disease Models, Animal; Drug Resistance; Glioma; Male; Meningeal Neoplasms; Neoplasm Transplantation; Nimustine; Nitrosourea Compounds; Rats; Rats, Inbred F344; Rats, Inbred Strains | 1984 |
Experimental study of intraoperative local chemotherapy with fibrin glue containing nitrosourea for malignant gliomas.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy; Fibrin Tissue Adhesive; Glioma; Male; Nimustine; Rats; Rats, Wistar; Time Factors; Treatment Outcome | 1995 |
Antitumor effect and peritumoral brain edema formation in relation to MX2, ACNU, and doxorubicin therapy: a comparative analysis using rodent models of gliomas.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Body Weight; Brain Edema; Brain Neoplasms; Carubicin; Disease Models, Animal; Doxorubicin; Glioma; Leukocyte Count; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Nimustine; Rats; Survival Rate | 2000 |
Intrathecal chemotherapy with ACNU in a meningeal gliomatosis rat model.
Topics: Animals; Disease Models, Animal; Glioma; Injections, Spinal; Male; Meningeal Neoplasms; Nimustine; Rats; Rats, Wistar | 1992 |
Preliminary experimental results with the nitrosourea derivative ACNU in the treatment of malignant gliomas.
Topics: Animals; Astrocytoma; Carmustine; Disease Models, Animal; Dose-Response Relationship, Drug; Lethal Dose 50; Mice; Mice, Nude; Nimustine; Nitrosourea Compounds; Oligodendroglioma; Transplantation, Heterologous | 1988 |
Experimental combination chemotherapy of ACNU and 5-FU against cultured glioma model (spheroid) and subcutaneous rat glioma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Colony-Forming Units Assay; Disease Models, Animal; Fluorouracil; Glioma; Male; Nimustine; Nitrosourea Compounds; Rats; Rats, Inbred Strains; Time Factors | 1987 |
[Regional blood flow of experimental brain tumors with special reference to effects of chemotherapy and radiotherapy].
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Capillary Permeability; Disease Models, Animal; Glioma; Male; Nimustine; Nitrosourea Compounds; Rats; Regional Blood Flow; Tumor Stem Cell Assay | 1985 |